A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...

Stephen Hoge was one of three kickers vying for the starting job at Kansas University. Hoge announced on Monday, August 18, that he has left the team. Stephen Hoge was one of three kickers vying ...

Despite a significant revenue decline, Moderna Inc (MRNA) focuses on strategic program prioritization and cost management to ...

President Stephen Hoge noted progress in pivotal studies for respiratory and non-respiratory vaccines. He shared updates on approvals filed for next-gen COVID, RSV, and flu-COVID combination ...

Stephen Hoge is one of three kickers vying for the starting job at Kansas University. Hoge is battling with fellow red-shirt freshman Jacob Branstetter and junior-college transfer Grady Fowler.

and that causes us to want to actually start to pace ourselves," Moderna President Stephen Hoge said. The company expects its shares to trade on the Nasdaq Global Market under the ticker symbol ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...